Certara FY2026 EPS Estimate Increased by Leerink Partnrs

Key Points

• Analysts at Leerink Partners have increased their FY2026 earnings per share (EPS) estimate for Certara to $0.35, up from $0.34, indicating positive expectations for the company's financial performance.
• Certara reported a net margin of 1.97% and a return on equity of 5.11%, with quarterly revenue of $104.57 million, reflecting a 12.1% year-over-year increase.
• Insider Leif E. Pedersen sold 51,224 shares of Certara stock, reducing his ownership by 40.91%, which may affect investor sentiment towards the company's management stability.

Certara, Inc. (NASDAQ:CERT - Free Report) - Analysts at Leerink Partnrs upped their FY2026 earnings per share (EPS) estimates for Certara in a research report issued on Wednesday, October 8th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings per share of $0.35 for the year, up from their prior estimate of $0.34. The consensus estimate for Certara's current full-year earnings is $0.28 per share. Leerink Partnrs also issued estimates for Certara's FY2028 earnings at $0.44 EPS.

Certara (NASDAQ:CERT - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported $0.07 earnings per share for the quarter, missing analysts' consensus estimates of $0.10 by ($0.03). The firm had revenue of $104.57 million for the quarter, compared to the consensus estimate of $104.14 million. Certara had a return on equity of 5.11% and a net margin of 1.97%.Certara's revenue for the quarter was up 12.1% on a year-over-year basis. During the same quarter last year, the business posted $0.07 EPS.

A number of other research firms also recently weighed in on CERT. Weiss Ratings reiterated a "sell (d)" rating on shares of Certara in a research report on Wednesday. UBS Group dropped their price target on shares of Certara from $17.50 to $15.00 and set a "buy" rating for the company in a research report on Thursday, August 7th. Craig Hallum assumed coverage on shares of Certara in a research report on Monday, September 29th. They issued a "buy" rating and a $16.00 price target for the company. Zacks Research upgraded shares of Certara from a "strong sell" rating to a "hold" rating in a research report on Friday, September 5th. Finally, KeyCorp lifted their price target on shares of Certara from $15.00 to $16.00 and gave the company an "overweight" rating in a research report on Wednesday. Six investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $15.63.

Certara Price Performance

Shares of NASDAQ CERT opened at $12.94 on Friday. Certara has a 1-year low of $8.64 and a 1-year high of $15.69. The business's 50 day moving average is $11.29 and its 200-day moving average is $11.40. The firm has a market cap of $2.08 billion, a P/E ratio of 258.85 and a beta of 1.45. The company has a current ratio of 2.16, a quick ratio of 2.16 and a debt-to-equity ratio of 0.27.

Insider Activity at Certara

In other news, insider Leif E. Pedersen sold 51,224 shares of Certara stock in a transaction on Tuesday, September 9th. The shares were sold at an average price of $10.92, for a total transaction of $559,366.08. Following the transaction, the insider owned 73,979 shares in the company, valued at approximately $807,850.68. The trade was a 40.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 2.33% of the company's stock.

Hedge Funds Weigh In On Certara

Hedge funds and other institutional investors have recently bought and sold shares of the company. Janney Montgomery Scott LLC acquired a new position in Certara in the first quarter valued at $120,000. Illinois Municipal Retirement Fund lifted its holdings in Certara by 3.9% in the first quarter. Illinois Municipal Retirement Fund now owns 59,721 shares of the company's stock valued at $591,000 after buying an additional 2,268 shares during the period. Northern Trust Corp lifted its holdings in Certara by 4.5% in the first quarter. Northern Trust Corp now owns 916,299 shares of the company's stock valued at $9,071,000 after buying an additional 39,289 shares during the period. Dynamic Technology Lab Private Ltd acquired a new position in Certara in the first quarter valued at $297,000. Finally, Principal Financial Group Inc. lifted its holdings in Certara by 2.4% in the first quarter. Principal Financial Group Inc. now owns 543,958 shares of the company's stock valued at $5,385,000 after buying an additional 12,513 shares during the period. Institutional investors and hedge funds own 73.96% of the company's stock.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.